Fibrocell Science Inc (FCSC) 2010年年度报告「NASDAQ」.pdf

1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-K Annual Report Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934For the fiscal year ended December 31,2010OR o Transition Report Pursuant to Section 13 or 15(d)of the Securities Exchange

2、 Act of 1934 Fibrocell Science,Inc.(Exact name of registrant as specified in its Charter.)Delaware 001-31564 87-0458888(State or other jurisdiction(Commission File Number)(I.R.S.Employerof incorporation)Identification No.)405 Eagleview BoulevardExton,Pennsylvania 19341(Address of principal executive

3、 offices,including zip code)(484)713-6000(Issuers telephone number,including area code)Securities registered pursuant to Section 12(g)of the Act:Title of Each Class Name of Each Exchange on which RegisteredCommon Stock,$.001 par value Over the Counter Bulletin Board Indicate by check mark if the reg

4、istrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes o No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Act.Yes o No Indicate by check mark whether the registrant:(1)filed all reports require

5、d to be filed by Section 13 or 15(d)of theExchange Act during the preceding 12 months(or for any shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No oIndicate by check mark whether the registrant has sub

6、mitted electronically and posted on its corporate Web site,if any,every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the registrant was required to submit and po